Biogenics Inc.
PrivateLast Round
Convertible Debt
Mar 30, 2026
Est. Valuation
$16M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biogenics Inc. operates in Healthcare & Life Sciences and is based in Daejeon. Its latest recorded funding round was a VC Round in February 2026.
Biogenics Inc. is a personal products company that specializes in the development and manufacturing of stabilized, solubilized cosmetic ingredients and bioactive materials using proprietary encapsulation technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biogenics Inc. Comparables
Compare Biogenics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| The Garden of Naturalsolution Co., Ltd. | 80% | |
| Dermalab Co., Ltd. | 79% | |
| Giga Fine Chemical Co., Ltd. | 78% |
For institutional investors. Book with your work email.
Biogenics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Mar 30, 2026 | ||||
| VC Round | Feb 12, 2026 | ||||
| VC Round | Jun 27, 2012 |
For institutional investors. Book with your work email.
Biogenics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Samsung Securities Co., Ltd. | VC Round |
| Innopolis Partners | VC Round |
| Sumitomo Corporation | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
$3.7M raised in convertible debt financing.
- Mar 17, 2025
Grew 43% QoQ from 120 to 172 employees.
For institutional investors. Book with your work email.
Biogenics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biogenics Inc.'s valuation, stock price, and market status.
Is Biogenics Inc. a public or private company?
Biogenics Inc. is a private company.
What is the current stock price of Biogenics Inc.?
Biogenics Inc. is a private company, so its shares have no public market price. Caplight tracks Biogenics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biogenics Inc. worth (valuation)?
Biogenics Inc.'s valuation is estimated at $16.0M based on funding round data.
Can I buy Biogenics Inc. stock?
Biogenics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biogenics Inc.'s last funding round?
Biogenics Inc.'s most recent funding round was Convertible Debt on March 30, 2026.
Who are the main investors in Biogenics Inc.?
Key investors in Biogenics Inc. include Samsung Securities Co., Ltd., Sumitomo Corporation.
Will Biogenics Inc. IPO soon?
No public IPO plans have been announced for Biogenics Inc..
How can I track Biogenics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Biogenics Inc.'s shares on secondary markets.